This site is intended for healthcare professionals
News

Phase IIIb EXCHANGE and EXPAND trials show Mayzent as safe in multiple sclerosis.- Novartis

Read time: 1 mins
Last updated:14th Sep 2020
Published:12th Sep 2020
Condition: Multiple Sclerosis
Type: drug
Register free for full access to medthority.com